‹ ›
MYP_150759
Basic Information
Satralizumab
Immunology ▸ Immune modulation ▸ Immunomodulatory activity
Standard
443 amino acids
C2155H3336N572O671S17
Standard
Sequence
QVQLQESGPGLVKPSETLSLTCAVSGHSISHDHAWSWVRQPPGEGLEWIGFISYSGITNYNPSLQGRVTISRDNSKNTLYLQMNSLRAEDTAVYYCARSLARTTAMDYWGEGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKSCVECPPCPAPPVAGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVVHQDWLNGKEYKCKVSNKGLPAPIEKTISKTKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQEGNVFSCSVMHEALHAHYTQKSLSLSP
Physicochemical Analysis
48538.08 Da
6.40
-2.43
-3.42
-0.0055
-0.37
0.65
0.02
43.37
70.07
0.0880
73340.00
73965.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Readable PDBLast file check: 2026-11-18T20:04:05.768119+00:00. File readability does not guarantee 3D display.
Match index: Listed
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0081596 REVIEWED: NO
Provenance & Taxonomy
Homo sapiens [Animal]; Cricetulus griseus [Animal]
Monoclonal antibody
9606;10029
Structure & Mods
cyclic peptide scaffold [Cyclic]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Immunomodulatory
The terminal half-life of satralizumab is approximately 30 days (range 22-37 days).[L15536]